CSIMarket Company Name, Ticker, Competitors, else..


G1 Therapeutics Inc   (NASDAQ: GTHX)
Other Ticker:  
 

G1 Therapeutics Inc

GTHX's Fundamental analysis



G1 Therapeutics Inc 's sales fell by -60.97 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 71

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.16 %

G1 Therapeutics Inc faced net loss in contrast to the net income a year ago in II. Quarter 2024

• More on GTHX's Growth


G1 Therapeutics Inc
realized a net loss in trailing twelve months.

G1 Therapeutics Inc realized cash reduction of $ -0.78 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.45.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.


• More on GTHX's Valuation
 
 Total Debt (Millions $) 44
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,238,191
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.96
 Tangible Book Value (Per Share $) 0.47

G1 Therapeutics Inc
realized net loss in trailing twelve months.

G1 Therapeutics Inc realized cash outflow of $ -0.78per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.45.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.28.

G1 Therapeutics Inc Price to Book Ratio is at 15.26 lower than Industry Avg. of 81.16. and higher than S&P 500 Avg. of 0.01

• More on GTHX's Valuation

•  Market Capitalization (Millions $) 375
•  Shares Outstanding (Millions) 52
•  Employees 47
•  Revenues (TTM) (Millions $) 58
•  Net Income (TTM) (Millions $) -45
•  Cash Flow (TTM) (Millions $) -41
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 44
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,238,191
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.96
•  Tangible Book Value (Per Share $) 0.47

•  Market Capitalization (Millions $) 375
•  Shares Outstanding (Millions) 52
•  Employees 47
•  Revenues (TTM) (Millions $) 58
•  Net Income (TTM) (Millions $) -45
•  Cash Flow (TTM) (Millions $) -41
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 2.48
•  Total Debt to Equity (MRQ) 1.8
•  Tangible Leverage Ratio (MRQ) 3.01
•  Asset Turnover Ratio (TTM) 0.53
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com